Status:

COMPLETED

Microglial Activation in Narcolepsy Type 1 and Kleine-Levin Syndrome: Positron Emission Tomography (PET) Study in [18F] DPA-714

Lead Sponsor:

University Hospital, Montpellier

Collaborating Sponsors:

Centre Hospitalier Universitaire de Nīmes

Conditions:

Narcolepsy 1

Kleine-Levin Syndrome

Eligibility:

All Genders

10+ years

Phase:

NA

Brief Summary

Type 1 narcolepsy (NT1) is a chronic sleep disorder caused by the selective and irreversible loss of neurons from the hypothalamus, which synthesizes a neurotransmitter: hypocretin (Hcrt) / orexin. Th...

Detailed Description

Formerly known as narcolepsy with cataplexy, narcolepsy type 1 (NT1) is a rare and disabling sleep pathology that affects 0.02% of the population. It occurs mainly in young adults and children, with r...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • For all groups :
  • Written agreement for participation
  • Able to understand instructions and information data
  • Without any immunomodulatory, immunosuppressant, or anti-inflamatory medication
  • For NT1 patients:
  • 10 years-old or more
  • Responding to NT1 criteria (ICSD-3)
  • Under psychostimulant or not for narcolepsy
  • For KLS patients:
  • 10 years-old or more
  • KLS diagnosis
  • For controls
  • 18 years-old or more
  • Absence of narcolepsy
  • Absence of acute or chronic inflammatory disease
  • Exclusion criteria (for all groups):
  • People without public insurance regime
  • Specific contraindication to the use of PET (specific allergy related to the ligand).
  • Pregnant and breastfeeding women
  • Persons deprived of liberty by judicial or administrative decision
  • People hospitalized without consent, or subject to legal protection
  • Persons unable to consent

Exclusion

    Key Trial Info

    Start Date :

    January 15 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    November 18 2021

    Estimated Enrollment :

    78 Patients enrolled

    Trial Details

    Trial ID

    NCT03754348

    Start Date

    January 15 2019

    End Date

    November 18 2021

    Last Update

    May 29 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University Hospital of Montpellier

    Montpellier, France